Bottom line
What is CPAYX's expense ratio?
CPAYX's expense ratio is 1.74%, or about $174 a year on every $10,000 invested. That is more expensive than 92% of dividend & equity income funds we track (median 0.74%). It has no front-end sales load. Its expense ratio includes a 1% 12b-1 marketing fee.
Updated Nov 26, 2025
CPAYX fee table
| Net expense ratio | 1.74% |
|---|---|
| Gross expense ratio | 3.19% |
| Management fee | 0.75% |
| 12b-1 (distribution) fee | 1% |
| Other expenses | 1.44% |
| Fee waiver / reimbursement | -1.45% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 1% |
Source: Fund prospectus fee table, filed Nov 26, 2025
What CPAYX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| CPAYX | $221 | $594 | $1,307 | $3,205 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.74% expense ratio costs roughly $90,400 in lost growth, versus about $41,900 for the median dividend & equity income fund (0.74%).